BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28339745)

  • 21. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
    Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
    Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between Wegener's granulomatosis and Staphylococcus aureus infection?
    van Putten JW; van Haren EH; Lammers JW
    Eur Respir J; 1996 Sep; 9(9):1955-7. PubMed ID: 8880118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
    Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-site and nasal swabbing for carriage of Staphylococcus aureus: what does a single nose swab predict?
    Young BC; Votintseva AA; Foster D; Godwin H; Miller RR; Anson LW; Walker AS; Peto TEA; Crook DW; Knox K
    J Hosp Infect; 2017 Jul; 96(3):232-237. PubMed ID: 28246002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections.
    Nouwen JL; Fieren MW; Snijders S; Verbrugh HA; van Belkum A
    Kidney Int; 2005 Mar; 67(3):1084-92. PubMed ID: 15698449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Shimojima Y; Kishida D; Hineno A; Yazaki M; Sekijima Y; Ikeda SI
    Int J Rheum Dis; 2017 Apr; 20(4):489-496. PubMed ID: 28217942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal carriers are more likely to acquire exogenous Staphylococcus aureus strains than non-carriers.
    Ghasemzadeh-Moghaddam H; Neela V; van Wamel W; Hamat RA; Shamsudin MN; Hussin NS; Aziz MN; Haspani MS; Johar A; Thevarajah S; Vos M; van Belkum A
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e1-7. PubMed ID: 26183299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients of 75 years and over with ANCA-associated vasculitis have a lower relapse risk than younger patients: A multicentre cohort study.
    Thietart S; Beinse G; Smets P; Karras A; Philipponnet C; Augusto JF; El Karoui K; Mesbah R; Titeca-Beauport D; Hamidou M; Carron PL; Maurier F; Sacre K; Cohen P; Liozon E; Blanchard-Delaunay C; Kostianovsky A; Pagnoux C; Mouthon L; Guillevin L; Terrier B; Puéchal X;
    J Intern Med; 2022 Mar; 291(3):350-363. PubMed ID: 34755398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis.
    Berti A; Felicetti M; Monti S; Ortolan A; Padoan R; Brunori G; Bortolotti R; Caporali R; Montecucco C; Schiavon F; Paolazzi G
    Semin Arthritis Rheum; 2020 Dec; 50(6):1441-1448. PubMed ID: 32173060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitis.
    de Souza AWS; van Timmeren M; Sanders JS; Stegeman C; Heeringa P; Kallenberg CGM; Westra J
    Arthritis Res Ther; 2017 May; 19(1):100. PubMed ID: 28521792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With Polyangiitis.
    Rhee RL; Lu J; Bittinger K; Lee JJ; Mattei LM; Sreih AG; Chou S; Miner JJ; Cohen NA; Kelly BJ; Lee H; Grayson PC; Collman RG; Merkel PA
    Arthritis Rheumatol; 2021 Sep; 73(9):1703-1712. PubMed ID: 33682371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease Activity and Tendency to Relapse in ANCA-Associated Vasculitis Are Reflected in Neutrophil and Intermediate Monocyte Frequencies.
    Smargianaki S; Elmér E; Lilliebladh S; Ohlsson S; Pettersson Å; Hellmark T; Johansson ÅC
    J Immunol Res; 2024; 2024():6648265. PubMed ID: 38213873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
    Klapa S; Müller A; Koch A; Kerstein-Stähle A; Kähler W; Heidecke H; Schinke S; Huber-Lang M; Nitschke M; Pitann S; Augustin S; Karsten CM; Riemekasten G; Lamprecht P
    Arthritis Rheumatol; 2023 May; 75(5):760-767. PubMed ID: 36409567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey.
    Pamuk ÖN; Dönmez S; Calayır GB; Pamuk GE
    Clin Rheumatol; 2016 Aug; 35(8):2063-2071. PubMed ID: 26992904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function.
    McGregor JG; Negrete-Lopez R; Poulton CJ; Kidd JM; Katsanos SL; Goetz L; Hu Y; Nachman PH; Falk RJ; Hogan SL
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1(Suppl 1):i171-81. PubMed ID: 25805747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host-microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients.
    Melles DC; Pauw E; van den Boogaard L; Boelens HA; Peters J; Peeters JK; Witsenboer H; van Leeuwen WB; Verbrugh HA; van Belkum A; Nouwen JL
    Microbes Infect; 2008 Feb; 10(2):151-8. PubMed ID: 18248760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: A hospital-based study with reference to the population-based National Health Insurance database.
    Wu CS; Hsieh CJ; Peng YS; Chang TH; Wu ZY
    J Microbiol Immunol Infect; 2015 Oct; 48(5):477-82. PubMed ID: 24560699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.